Jul 20, 2026 01:00AM

Jul 7, 2026 01:00AM

Mar 28, 2026 11:00AM

Feb 27, 2026 01:00AM

Jan 30, 2026 01:00AM

Dec 17, 2025 01:00AM

Dec 11, 2025 01:00AM Galderma Announces First Patient Enrollment in Study to Assess Nemolizumab in Adults With Chronic Pruritus of Unknown Origin

Nov 17, 2025 01:00AM

Sep 24, 2025 01:00AM

Jul 24, 2025 01:00AM

Jun 25, 2025 01:00AM

Jun 18, 2025 01:00AM

Jun 12, 2025 06:11AM

Jun 6, 2025 01:00AM RAD 2025: Long-Term Data on Nemluvio® (nemolizumab) Demonstrate its Favorable Safety Profile and Sustained and Increased Improvements in Itch and Skin Lesions in Patients With Atopic Dermatitis up to

Feb 18, 2025 01:00AM

Feb 14, 2025 01:00AM

Dec 13, 2024 05:09PM

Dec 13, 2024 01:00AM

Nov 28, 2024 01:00AM

Sep 25, 2024 01:00AM

Aug 13, 2024 01:01AM Galderma Receives U.S. FDA Approval for Nemluvio® (nemolizumab) for Adult Patients Living With Prurigo Nodularis

67,583 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All